Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease.

Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease.

http://www.wikidata.org/entity/Q48747176

about

PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice Cerebral metabolism, anatomy, and cognition in monozygotic twins discordant for dementia of the Alzheimer type.Dominantly inherited Alzheimer's disease: cerebral glucose metabolism Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer type Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative Drug development for neurodegenerative diseases: role of PET.Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine.Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia.Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis Using biomarkers to improve detection of Alzheimer's disease.Understanding dementia prevalence among centenarians.Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.Regional correction of positron emission tomography data for the effects of cerebral atrophy.The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.Behavioral and omics analyses study on potential involvement of dipeptide balenine through supplementation in diet of senescence-accelerated mouse prone 8.Quantitative evaluation of Alzheimer's disease.Imaging dementia with SPECT.The concept of FDG-PET endophenotype in Alzheimer's disease.Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.Brain metabolism in health, aging, and neurodegeneration.Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia.Glucose metabolism and rate constants in Alzheimer's disease examined with dynamic positron emission tomography scan.Brain functional network in Alzheimer's disease: diagnostic markers for diagnosis and monitoring.Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.Magnetic resonance imaging evaluation of the effects of ageing on grey-white ratio in the human brain.Topographical analysis of glucose metabolism, as measured with positron emission tomography, in dementia of the Alzheimer type: use of linear histograms.Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.Changes in brain monoaminergic neurotransmitter concentrations in rat after intracerebroventricular injection of streptozotocin.Human brain glucose utilization and cognitive function in relation to age.Decreases in regional cerebral blood flow with normal aging.Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease.Metabolic brain networks in aging and preclinical Alzheimer's disease.Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy.Mitochondrial Chaperones in the Brain: Safeguarding Brain Health and Metabolism?

P2860

Q24604133-ADC1C7B4-E8A8-4E0F-8D92-6280294E831F Q30573779-48C5B49A-E699-4223-9CFA-E0B4366067C2 Q33627955-C25C618E-F584-4729-9360-C37834A5A12F Q33628634-BC9CFC88-00E0-4B09-90F4-FCC265BFBAE3 Q33628645-77501CBC-4355-456A-8DCF-15209BCC87B6 Q33629964-D1181DDA-D963-4B35-93F9-94765AB35C10 Q33651118-E40D1F66-F5F9-42DD-992B-154FBDB6ADDA Q33798435-C2B097DA-736C-4FE2-9642-C1A11FEAEED1 Q33841672-DB662E0A-7BC3-4C9A-8B54-E2E862CBACAB Q33917702-8480E8AB-5796-4058-A4F6-6A2F3163783E Q34879008-881A9183-2FA9-4C8F-9094-F400A4104AF9 Q35117821-4AF7580B-33CA-482C-ABC2-0D298BA9F7CB Q35120662-8F691818-306D-4BEE-9F5B-F23FB6BB2BF3 Q35158547-61419FCF-DDCF-468C-9740-3999ED4CFCE1 Q35533115-7873DEEB-6F44-4A21-8FB6-388FAD5F5121 Q35845305-CCD2D1CC-C52C-45EC-9D8F-CD1E23DA6004 Q36098880-1E84CEDA-AEB1-4DAC-8E80-C18EA9168783 Q36443786-0AB2181A-89E2-48F8-843E-EEA361FE9B70 Q37108142-B281B0D2-588E-46E4-9951-9313914F3A85 Q37270852-B5D3D6FA-08DF-4F89-B440-E4C4CA064070 Q37596431-5C02440D-B535-48DC-B793-2941B6DD253F Q37722803-4AEBC219-91B3-4C8E-8B63-F7B0DF2045FC Q37883153-487508CF-1C75-4EF2-8A32-8DE308D7E6F6 Q38773531-92B918DD-101A-402D-BA8B-77BB0793F1C5 Q39259780-9B92C097-9090-406E-B0E9-36B87F92DCB6 Q39856970-EE209882-7843-45BA-846C-BBC7B62202D3 Q42123032-64B715C1-64CD-4E9E-A790-1B9612E9F873 Q42124171-F23878B6-C813-4FC2-B2DC-76C22EE76FE3 Q46502975-1767F055-772A-4075-8104-81E42F33F622 Q48116199-73ECC7B4-A0E2-4A28-8D2A-F67F6F1DD2E6 Q48213415-83C9F46F-52E0-4A51-B911-B8159EDADD0E Q48483328-CE755C7D-6A72-4950-BB05-C9A13A346907 Q48591271-04F8AB74-1410-4D8B-AE71-D7AB79A2DCF9 Q48597174-28ECD093-AC8A-459F-BDB7-C8E763E5DD5F Q48692518-8E7E2757-55E6-4938-BE0E-68760704CCAD Q48799327-ECB607D4-2026-409D-B2CF-C9C902669C04 Q50531249-1A9A956D-6580-4D5A-8A29-703BAAAE9D9E Q52062294-E8F6405C-855F-4A34-B362-318DD376B500 Q55283805-FB5E1724-7A60-4530-BBBF-A37B493154AD

P2860

Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease.

http://www.wikidata.org/entity/Q48747176

description

1983 nî lūn-bûn

@nan

1983年の論文

@ja

1983年学术文章

@wuu

1983年学术文章

@zh

1983年学术文章

@zh-cn

1983年学术文章

@zh-hans

1983年学术文章

@zh-my

1983年学术文章

@zh-sg

1983年學術文章

@yue

1983年學術文章

@zh-hant

name

Computed tomography and positr ...... aging and Alzheimer's disease.

@en

Computed tomography and positr ...... aging and Alzheimer's disease.

@nl

type

label

Computed tomography and positr ...... aging and Alzheimer's disease.

@en

Computed tomography and positr ...... aging and Alzheimer's disease.

@nl

prefLabel

Computed tomography and positr ...... aging and Alzheimer's disease.

@en

Computed tomography and positr ...... aging and Alzheimer's disease.

@nl

P1433

Q48747176-549B59B5-AB9F-4515-AF90-2BD3200613BE

P1476

Q48747176-7911B9FC-0827-4B8B-9D9F-F4391027E1F3

P2093

Q48747176-2B1FA601-699F-4AA4-A6C4-FFCB6A6E3182

Q48747176-8E488CD8-A23A-406F-B133-A451FA974C1D

Q48747176-E52BFC03-06F2-41D6-AC9F-6CE9374144F9

P2860

Q48747176-0187269B-4560-40C2-B208-333101AEE660

Q48747176-0DC616F1-7BE7-4EC2-AAE0-1B6544CC9068

Q48747176-22CA447C-74E9-47C3-A325-C97EF1A65E07

Q48747176-25147B20-EDD9-46F2-BB22-7578E634BF56

Q48747176-2F1A8D3B-3E92-452C-A572-E64762796048

Q48747176-5D9A0C72-7AE1-4C57-BD97-77EE57510C98

Q48747176-5F167807-1D5A-4D91-92A8-21B5C5BA7A9B

Q48747176-7607EE91-1474-4027-8989-BA51C124A907

Q48747176-7A7B8DF6-F029-4756-B5D4-AAA56E693F87

Q48747176-8F0DA96A-D069-48EF-9FAB-B0FBA323DF2D

P304

Q48747176-3F907E74-1237-46FE-8A6C-B240B8EBC987

P31

Q48747176-03BB3BA5-040D-420E-96F5-845FE5538FFF

P356

Q48747176-CB480E9E-745E-4860-B5D6-5FBD5A828D1C

P433

Q48747176-B1EF3877-7669-4D0F-BB17-EBBA98F220AC

P478

Q48747176-4F774D75-262E-46EC-B8DA-A79757894512

P50

Q48747176-4CF56392-371F-43CC-847F-179A90196C9A

Q48747176-76544EDA-9830-460F-BBD8-A51E6A0A25E8

Q48747176-7BD73CA6-126A-48F8-BA9E-4FC183272843

Q48747176-D42D1173-CDB6-4661-8A66-C735351ED760

P577

Q48747176-C163EDF0-FDED-403C-BE64-24B3F8C7056D

P5875

Q48747176-3B885518-9249-4BF4-8B2D-7BEBA16C7EBF

P698

Q48747176-A364326C-90F9-49CE-AE80-A2055CE2C34C

P921

Q48747176-C030770C-F342-475F-93F1-D9B0E6F6B445

P356

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Computed tomography and positr ...... aging and Alzheimer's disease

@en

P2093

Christman DR

http://www.w3.org/2001/XMLSchema#string

Kricheff II

http://www.w3.org/2001/XMLSchema#string

Wolf AP

http://www.w3.org/2001/XMLSchema#string

P2860

Bilateral studies of cerebral oxygen uptake in young and aged normal subjects and in patients with organic dementia

Frontal ventricular dimensions on normal computed tomography.

Measurements of the normal ventricular system with computer tomography of the brain. A preliminary study on 44 adults.

Cognitive reduction in presenile dementia related to regional abnormalities of the cerebral blood flow.

Changes in size of normal lateral ventricles during aging determined by computerized tomography.

Regional cerebral blood flow and its regulation in dementia.

Volumetric measurements of the cerebrospinal fluid spaces in demented subjects and controls.

Regional cerebral blood flow in senile and presenile dementia.

Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.

Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

P304

391-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JCBFM.1983.57

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Steven H Ferris

P577

1983-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232776631

http://www.w3.org/2001/XMLSchema#string

P698

6603463

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease